YMC acquires ChromaCon AG -pioneer in continuous chromatography
YMC expands footprint in multi-column continuous purification technologies with purchase of ChromaCon and additional investment in Asia planned for 2019. Learn More.
Previous Article
YMC At Pittcon 2019 in Philadelphia Related Posts
June 2, 2026
Chromatography of Biotherapeuticals – Analyzing and Purifying Peptides and Oligonucleotides
This webinar will highlight how advanced ultra-high-performance liquid chromatography (UHPLC) strategies, carefully selected stationary phases, and bioinert hardware can significantly improve the analysis and purification of peptides and oligonucleotides.
May 21, 2026
Breaking Down mRNA Capping Efficiency with High-Resolution IP-RP LC
Evaluating 5' capping efficiency is a critical quality attribute in therapeutic mRNA manufacturing, directly impacting translation efficiency and transcript stability. However, separating structurally similar capped, partially capped, and uncapped species differing by just a single nucleotide remains a significant chromatographic challenge.
May 7, 2026
Revolutionizing CRISPR Applications: High-Resolution sgRNA Analysis
Ensuring the quality of single guide RNA (sgRNA) is a major hurdle in CRISPR-Cas genome editing. Because these molecules are large (~100mer) and prone to complex secondary structures, separating them from nearly identical impurities requires precision. Our latest application note
